OR7A10 Inhibitors
OR7A10 inhibitors are specialized chemical compounds that selectively target the olfactory receptor 7A10 (OR7A10), a member of the G protein-coupled receptor (GPCR) family involved in olfaction. These inhibitors function by binding to the active site or allosteric sites of OR7A10, thereby modulating its ability to interact with natural odorant molecules. OR7A10 plays a role in the detection of specific volatile compounds, contributing to the complex process of smell perception. By inhibiting this receptor, researchers can alter olfactory signal transduction pathways, which is essential for studying the molecular mechanisms underlying olfaction.
The development of OR7A10 inhibitors involves intricate organic synthesis and computational modeling to achieve high specificity and affinity for the receptor. Scientists employ techniques such as molecular docking studies to predict how these inhibitors interact with OR7A10 at the atomic level. The chemical structures of these inhibitors are often designed to mimic or block natural ligands, enabling precise modulation of receptor activity. Synthesis requires careful manipulation of functional groups to optimize binding characteristics. Studying OR7A10 inhibitors provides valuable insights into the structure-function relationships of olfactory receptors and enhances our understanding of sensory perception at the molecular level. This research contributes to the broader field of neurobiology by illuminating how specific receptors influence neural signaling pathways associated with the sense of smell.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This compound could induce hypomethylation of the OR7A10 gene promoter, potentially leading to a downregulation of its transcription by disrupting epigenetic silencing. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
TSA may cause hyperacetylation of histones near the OR7A10 gene, potentially leading to a compact chromatin structure and decreased access for transcriptional machinery. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
Valproic acid could reduce the deacetylation of histones associated with the OR7A10 gene, potentially resulting in downregulated expression due to altered chromatin conformation. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
This chemical is known to intercalate into DNA, which could block the transcriptional elongation process of the OR7A10 gene, leading to a decrease in its mRNA synthesis. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
By specifically inhibiting RNA polymerase II, α-Amanitin may lead to a substantial decrease in the transcription levels of OR7A10, resulting in lower mRNA availability. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin could inhibit the mTOR pathway, which might reduce the translation of transcription factors involved in the upregulation of OR7A10, thus leading to decreased expression. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
This compound could inhibit the ribosomal translocation, leading to halted protein synthesis; this might result in a reduced expression of transcription factors necessary for OR7A10 transcription. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
By binding to DNA in the OR7A10 promoter region, Mithramycin A could prevent the binding of transcriptional activators, which would lead to decreased expression of OR7A10. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine could raise the internal vesicular pH, potentially leading to a destabilization of the OR7A10 mRNA transcript and a subsequent decline in protein synthesis. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $110.00 $250.00 $936.00 $50.00 | 33 | |
As an antioxidant, Quercetin could interfere with signaling pathways by reducing oxidative stress-related transcription factor activation, potentially leading to decreased OR7A10 expression. | ||||||